Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 1;123(1):81-89.
doi: 10.1002/cncr.30246. Epub 2016 Aug 29.

Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States

Affiliations

Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States

Ju Dong Yang et al. Cancer. .

Abstract

Background: There is global variation in the onset of hepatocellular carcinoma (HCC). The objective of the current study was to investigate the impact of country of birth on age at the time of HCC diagnosis in the United States.

Methods: Incident HCC cases diagnosed between 2000 and 2012 in the Surveillance, Epidemiology, and End Results program 18 registry were included. Factors associated with very early onset (age at diagnosis < 40 years) and early onset (age at diagnosis < 50 years) were identified by logistic regression.

Results: A total of 59,907 patients were included. The median age at the time of diagnosis of HCC was 62 years and 76% of the patients were male. Of the 75% of patients for whom information regarding birth country was available, 29% were foreign born. In multivariate logistic regression, birth in West Africa (adjusted odds ratio [AOR], 16.3; 95% confidence interval [95% CI], 9.2-27.9 [P<.01]), Central/South/other Africa (AOR, 11.0; 95% CI, 4.5-23.7 [P<.01]), Oceania (AOR, 4.9; 95% CI, 2.9-8.0 [P<.01]), and East Africa (AOR, 3.5; 95% CI, 1.5-6.8 [P<.01]) was found to have the strongest association with very early-onset HCC after adjusting for sex and race/ethnicity. Birth in West Africa, Central/South/other Africa, Oceania, or East Africa also was found to be strongly associated with early-onset HCC.

Conclusions: Birth country was found to be independently associated with age at the time of HCC diagnosis in the United States. Birth in Africa (except for North Africa) and Oceania was strongly associated with very early-onset HCC. These findings have implications for the design of comprehensive HCC surveillance programs in the United States. Cancer 2016. © 2016 American Cancer Society. Cancer 2017;81-89. © 2016 American Cancer Society.

Keywords: Africa; Oceania; age; early onset; liver cancer.

PubMed Disclaimer

Conflict of interest statement

Nothing to disclose

Figures

Figure 1
Figure 1. Trends of proportions of foreign born HCC patients in the US SEER 18 registries
Joinpoint regression annual percent change in foreign born place of birth by race and ethnicity The overall trend is −1.12% *, white −1.65%, black −2.64%, API −0.34%*, and Hispanic 0.70%. * indicates P<0.05
Figure 2
Figure 2. Global map showing the median age of HCC diagnosis by country or region of birth among individuals with HCC in the US SEER 18 registries
Global map was generated based on the specific country data when the number of individuals born in the specific country were ≥10. If the number of individuals born in the specific country were < 10, then that area was mapped based on the regional data. Oceania were colored-coded by outline of rectangle.
Figure 3
Figure 3. Global map showing the proportion of early onset HCC (age of HCC diagnosis <50) by country or region of birth among individuals with HCC in the US SEER 18 registries
Global map was generated based on the each country data when the number of individuals born in the specific country were ≥10. If the number of individuals born in the specific country were < 10, then that area was mapped based on the regional data. Oceania were colored-coded by outline of rectangle.

References

    1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: a cancer journal for clinicians. 2011;61:69–90. - PubMed
    1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27:1485–91. - PMC - PubMed
    1. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology. 2006;45:529–38. - PubMed
    1. Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. The American journal of gastroenterology. 2014;109:542–53. - PMC - PubMed
    1. Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nature reviews Gastroenterology & hepatology. 2010;7:448–58. - PMC - PubMed